• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Farnesyltransferase Inhibitors in Cancer Therapy

Farnesyltransferase Inhibitors in Cancer Therapy

Hardcover

Series: Cancer Drug Discovery & Development

Medical Reference

ISBN10: 0896036294
ISBN13: 9780896036291
Publisher: Springer Nature
Published: Oct 22 2000
Pages: 280
Weight: 1.61
Height: 0.69 Width: 7.00 Depth: 10.00
Language: English
Cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farensyltransferase inhibitors (FTIs); geranylgeranyltransferase inhibitors (GGTIs) are also discussed as potential anticancer drugs. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.

1 different editions

Also available

Also in

Medical Reference